-
1
-
-
0024462761
-
A quality-of-life-oriented endpoint for comparing therapies
-
R.D. Gelber, R.S. Gelman, and A. Goldhirsch A quality-of-life-oriented endpoint for comparing therapies Biometrics 45 1989 781 795
-
(1989)
Biometrics
, vol.45
, pp. 781-795
-
-
Gelber, R.D.1
Gelman, R.S.2
Goldhirsch, A.3
-
2
-
-
22544476793
-
The QALY model and individual preferences for health states and health profiles over time: A systematic review of literature
-
A. Tsuchiya, and P. Dolan The QALY model and individual preferences for health states and health profiles over time: a systematic review of literature Med Decis Making 25 2005 460 467
-
(2005)
Med Decis Making
, vol.25
, pp. 460-467
-
-
Tsuchiya, A.1
Dolan, P.2
-
3
-
-
33645101095
-
Analyzing oncology clinical trial data using the Q-TWiST method: Clinical importance and sources for health state preference data
-
D.A. Revicki, D. Feeny, T.L. Hunt, and B.F. Cole Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data Qual Life Res 15 2006 411 423
-
(2006)
Qual Life Res
, vol.15
, pp. 411-423
-
-
Revicki, D.A.1
Feeny, D.2
Hunt, T.L.3
Cole, B.F.4
-
4
-
-
0037252456
-
Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework
-
N. Mounier, C. Ferme, H. Flechtner, M. Henzy-Amar, and E. Lepage Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework Med Decis Making 23 2003 54 66
-
(2003)
Med Decis Making
, vol.23
, pp. 54-66
-
-
Mounier, N.1
Ferme, C.2
Flechtner, H.3
Henzy-Amar, M.4
Lepage, E.5
-
5
-
-
0036221470
-
A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot
-
J.A. Sloan, D.J. Sargent, and J. Lindman et al. A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot Qual Life Res 11 2002 37 45
-
(2002)
Qual Life Res
, vol.11
, pp. 37-45
-
-
Sloan, J.A.1
Sargent, D.J.2
Lindman, J.3
-
6
-
-
0037093059
-
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: An updated decision analysis
-
V.R. Grann, J.S. Jacobson, and D. Thomason et al. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis J Clin Oncol 20 2002 2520 2521
-
(2002)
J Clin Oncol
, vol.20
, pp. 2520-2521
-
-
Grann, V.R.1
Jacobson, J.S.2
Thomason, D.3
-
7
-
-
70349304187
-
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: An analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
-
R.W. Jang, A. Le Maitre, and K. Ding et al. Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial J Clin Oncol 27 2009 4268 4273
-
(2009)
J Clin Oncol
, vol.27
, pp. 4268-4273
-
-
Jang, R.W.1
Le Maitre, A.2
Ding, K.3
-
8
-
-
67650503830
-
Long-term outcome and quality-adjusted life years after severe sepsis
-
Finnsepsis Study Group
-
S. Karlsson, E. Ruokonen, T. Varpula, T.I. Ala-Kokko, V. Pettila Finnsepsis Study Group Long-term outcome and quality-adjusted life years after severe sepsis Crit Care Med 37 2009 1268 1274
-
(2009)
Crit Care Med
, vol.37
, pp. 1268-1274
-
-
Karlsson, S.1
Ruokonen, E.2
Varpula, T.3
Ala-Kokko, T.I.4
Pettila, V.5
-
9
-
-
76149090862
-
Comparative effectiveness and health care spending - Implications for reform
-
M.C. Weinstein, and J.A. Skinner Comparative effectiveness and health care spending - implications for reform N Engl J Med 362 2010 460 465
-
(2010)
N Engl J Med
, vol.362
, pp. 460-465
-
-
Weinstein, M.C.1
Skinner, J.A.2
-
10
-
-
61349170102
-
Retaining, and enhancing, the QALY
-
J. Lipscomb, M. Drummond, D. Fryback, M. Gold, and D. Revicki Retaining, and enhancing, the QALY Value in Health 12 2009 S18 S26
-
(2009)
Value in Health
, vol.12
-
-
Lipscomb, J.1
Drummond, M.2
Fryback, D.3
Gold, M.4
Revicki, D.5
-
11
-
-
79960145633
-
Using QALYs in cancer: A review of the methodological limitations
-
M. Garau, K.K. Shah, and A.R. Mason et al. Using QALYs in cancer: a review of the methodological limitations Pharmacoeconomics 29 2011 673 685
-
(2011)
Pharmacoeconomics
, vol.29
, pp. 673-685
-
-
Garau, M.1
Shah, K.K.2
Mason, A.R.3
-
12
-
-
36048972049
-
Applying QOL assessments: Solution for oncology clinical practice and research, part 2
-
J.A. Sloan, A. Dueck, and M.H. Frost et al. Applying QOL assessments: solution for oncology clinical practice and research, part 2 Curr Probl Cancer 30 2006 235 331
-
(2006)
Curr Probl Cancer
, vol.30
, pp. 235-331
-
-
Sloan, J.A.1
Dueck, A.2
Frost, M.H.3
-
13
-
-
1542289007
-
A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced cancer
-
B.F. Cole, R.D. Gelber, S. Gelber, and P. Mukhopadhyay A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced cancer J Biopharm Stat 14 2004 111 124
-
(2004)
J Biopharm Stat
, vol.14
, pp. 111-124
-
-
Cole, B.F.1
Gelber, R.D.2
Gelber, S.3
Mukhopadhyay, P.4
-
14
-
-
77954631440
-
Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved
-
K.L. Kilbridge Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved Oncology 24 2010 530 537
-
(2010)
Oncology
, vol.24
, pp. 530-537
-
-
Kilbridge, K.L.1
-
15
-
-
0028872887
-
Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2α in selected patients with malignant melanoma
-
E.T. Creagan, R.J. Dalton, and D.L. Ahmann et al. Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2α in selected patients with malignant melanoma J Clin Oncol 13 1995 2776 2783
-
(1995)
J Clin Oncol
, vol.13
, pp. 2776-2783
-
-
Creagan, E.T.1
Dalton, R.J.2
Ahmann, D.L.3
|